-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 D4xFrtBZ9gd0cBot3Bq9aaIyF4Jj9zTLsUjKrJH1wrDZy4SLp6/ujBY4ity4PD+A
 b/28yNpyhg2EzZ3IaC9QLA==

<SEC-DOCUMENT>0000846475-04-000003.txt : 20040204
<SEC-HEADER>0000846475-04-000003.hdr.sgml : 20040204
<ACCEPTANCE-DATETIME>20040204130922
ACCESSION NUMBER:		0000846475-04-000003
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20040203
ITEM INFORMATION:		Changes in control of registrant
FILED AS OF DATE:		20040204

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ZYNEX MEDICAL HOLDINGS   INC
		CENTRAL INDEX KEY:			0000846475
		STANDARD INDUSTRIAL CLASSIFICATION:	ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
		IRS NUMBER:				870403828
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			0930

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	033-26787-D
		FILM NUMBER:		04565799

	BUSINESS ADDRESS:	
		STREET 1:		4766 HOLLADAY
		STREET 2:		BLVD.
		CITY:			HOLLADAY
		STATE:			UT
		ZIP:			84117
		BUSINESS PHONE:		8012739300

	MAIL ADDRESS:	
		STREET 1:		SHERRY MCEVOY
		STREET 2:		848 RAINBOW BLVD 221
		CITY:			LAS VEGAS
		STATE:			NV
		ZIP:			89107

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	FOX RIVER HOLDINGS  INC
		DATE OF NAME CHANGE:	20031126

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ARIZONA VENTURES INC
		DATE OF NAME CHANGE:	20030115

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CHINA GLOBAL DEVELOPMENT INC
		DATE OF NAME CHANGE:	20020130
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>zynex8k.htm
<TEXT>
<HTML>
<HEAD>
</HEAD>
<BODY TEXT="#000000" LINK="#0000ff" VLINK="#551a8b" ALINK="#ff0000" BGCOLOR="#FFFFFF">

<hr size="6" color="#0000FF">

<P ALIGN="CENTER"><STRONG><FONT SIZE="+1">SECURITIES AND EXCHANGE COMMISSION<br>
WASHINGTON, D.C. 20549</STRONG></FONT></P>

<P ALIGN="CENTER"><STRONG><FONT SIZE="+1">FORM 8-K </STRONG></FONT><FONT SIZE="+1"></FONT></P>

<P ALIGN="CENTER">CURRENT REPORT<br>
PURSUANT TO SECTION 13 OR 15(d) OF THE<br>
SECURITIES EXCHANGE ACT OF 1934 </P>

<P>Date of earliest event reported: <U>January 27, 2004 </U> </P>

<P align="center"><STRONG>ZYNEX MEDICAL HOLDINGS, INC.</STRONG><STRONG><U><br>
(Formerly Fox River Holdings, Inc.)<br>
</U></STRONG>(Exact name of registrant as specified in charter)
</P>

<BR WP="BR1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>    Nevada&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
33-26787-D&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
87-0403828<br>
</U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
(State or other jurisdiction&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (Commission&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
(IRS employer<br>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
of incorporation)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
file number)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
identification no.)
<p align="center">378 North Main, #124.<U><br>
Logan, Utah 84041<br>
</U>Address of Principal Executive Offices)</p>
<P>Registrant's telephone number, including area code (801) 497-9075</P>

<P>&nbsp;</P>

<hr color="#0000FF">
<P><STRONG>Item 1. Change in Control of Registrant</STRONG></P>

<P>	hough Zynex Medical Holdings, Inc., ("the Company"), has not experienced a change in
control, due to recent corporate events, there is a likelihood that such change will occur.
Consequently, the Company has decided to provide the following information.</P>

<P>	Effective January 27, 2004, the Company entered into an Agreement to acquire all the of
equity of Zynex Medical, Inc. ("Zynex"), a privately-held Colorado corporation.  If the intended
transaction closes, Zynex will become a wholly-owned subsidiary of the Company through a merger
with a new subsidiary of the Company and there would be a complete change of management.</P>

<P>	Pursuant to the intended transaction, the shareholders of Zynex will be issued 19.5 million
shares of common stock and become the controlling shareholders of the Company.  The total number
of shares that would be outstanding if the transaction closes would be approximately 22.5 million
shares. </P>

<P>	In anticipation of closing the acquisition, Thomas Sandgaard has been appointed to fill a
vacancy on the Company's Board of Directors.  Mr. Sandgaard is President of Zynex.  Upon the
closing of acquisition, Mr. Sandgaard will be appointed President and CEO of the Company and the
Company's current president will resign as an officer and director.</P>

<P><STRONG>Item 5. Other Events</STRONG></P>

<P>	On January 29, 2004, the Company signed a Acquisition Agreement to acquire all the of
equity of Zynex Medical, Inc. </P>

<P>

<BR WP="BR1">In the first week of January, 2004, the Company successfully restructured its debt obligations.
Approximately two million six hundred thousand shares have been issued for conversion of
approximately $360,000 in debt.<BR WP="BR2">
 </P>

<P><STRONG>Item 7. Financial Statements, <EM>Pro Forma</EM> Financial Information and Exhibits.</STRONG>

<BR WP="BR1"><BR WP="BR2">
(a) and (b)  If the Company completes the intended transaction with Zynex, another Form 8K
will be filed and any required financial statements will be filed no later than 60 days after the date
of closing.</P>

<BR WP="BR1"><BR WP="BR2">
<BR WP="BR1">
<hr color="#0000FF">
<p align="center"><BR WP="BR2">
<STRONG>SIGNATURES</STRONG></p>

<BR WP="BR1">	Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly
caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
<p>&nbsp;
<P>							<STRONG>ZYNEX MEDICAL HOLDINGS, INC</STRONG>.<BR WP="BR2">
</P>

<P>				</P>

<P>Date: February 3, 2004			By:	<U> /s/ Paul Beatty<br>
</U>Paul Beatty,  President/CEO</P>

<BR WP="BR1"><BR WP="BR2">
<hr color="#0000FF" size="8">
</BODY>
</HTML>

</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
